Resource Central is a product of the Pediatric Pandemic Network.

Nirsevimab Library

This is a collection of current resources related to Nirsevimab.

1120 of over 100 results
Indian Health Service Nirsevimab Vaccine Update
2024 · Indian Health Service
This document provides information on nirsevimab and recommendations for its use, including an administration visual guide. It addresses the documentation of administered doses and reconciliation …
MedlinePlus: Nirsevimab-alip
2024 · American Society of Health-System Pharmacists (ASHP), · U.S. Department of Health and Human Services (HHS)
This webpage provides drug information on nirsevimab-alip (brand name: Beyfortus®). It addresses why and how it should be used, special precautions, and side effects.
Nirsevimab Administration Visual Guide
2024 · American Academy of Pediatrics (AAP)
This 2-page infographic includes a flowchart to aid in making decisions about nirsivemab administration and dosing in infants and toddlers. It provides immunization administration tips, …
Drug Trials Snapshots: BEYFORTUS
2024 · U.S. Food and Drug Administration
This webpage features a drug trial snapshot for the drug Beyfortus, a monoclonal antibody given as an injection to protect against RSV. Snapshots reveal participants …
ACIP Evidence to Recommendations for Use of Nirsevimab in Children 8–19 Months of Age at Increased Risk of Severe Disease Entering Their Second RSV Season
2024 · Centers for Disease Control and Prevention (CDC)
This webpage provides evidence for the recommendations made by the Advisory Committee on Immunization Practices (ACIP) for the use of nirsevimab for a population of …
The Respiratory Syncytial Virus Vaccine and Monoclonal Antibody Landscape: The Road to Global Access
2024 · University Medical Center Utrecht, · Yenepoya University, · University of Edinburgh, · National Institutes of Health (NIH), · London School of Hygiene and Tropical Medicine, · London School of Hygiene & Tropical Medicine
This article is about the fight against respiratory syncytial virus (RSV), a major cause of illness in infants and older adults. It describes new vaccines …
Beyfortus-nirsevimab injection (Drug Label Information)
2024 · National Library of Medicine
This webpage provides drug label information for the Beyfortus- nirsevimab injection. It describes the drug's dosage, forms, and strengths. Beyfortus is given as an injection …
Nirsevimab (Beyfortus) Product & Ordering Information
2024 · American Academy of Pediatrics (AAP)
This webpage provides information about nirsevimab (Beyfortus), describing the different doses available, how to order and store it, and its cost. Practices need to forecast …
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024
2024 · Centers for Disease Control and Prevention (CDC), · U.S. Public Health Service, · University of Rochester, · University of Cincinnati, · Cincinnati Children's Hospital Medical Center, · Vanderbilt University, · Texas Children's Hospital, · Baylor College of Medicine, · University of Washington, · University of Pittsburgh, · Children's Mercy Kansas City
This study looks at the impact of respiratory syncytial virus (RSV) in young children during the 2023-2024 season. It describes how two new RSV prevention …
Potential Effects on Elderly People From Nirsevimab Use in Infants
2024 · World Health Organization (WHO), · Instituto de Estudios de Ciencias de la Salud de Castilla y León, ICSCYL, · Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFECC), · University of Valladolid
This article is about nirsevimab, a new treatment for infants to prevent severe RSV disease. It describes how using nirsevimab in babies might help protect …

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie
1120 of over 100 results